Evidence map›Paper›PMID 38793037›Full record

ArticleJournal of personalized medicine2024

New Insight into Laryngo-Tracheal Surgery: High-Flow Oxygen Therapy to Prevent Early Complications after Surgery.

Beatrice Trabalza Marinucci, Silvia Fiorelli, Alessandra Siciliani, Cecilia Menna, Matteo Tiracorrendo, Domenico Massullo, Federico Venuta, Erino Angelo Rendina, Anna Maria Ciccone, Antonio D'Andrilli and 2 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Beatrice Trabalza MarinucciThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.ORCID 0000-0002-3786-5716
Silvia FiorelliAnesthesiology and Intensive Care, Sant'Andrea Hospital, La Sapienza University, 00189 Rome, Italy.ORCID 0000-0002-4116-1199
Alessandra SicilianiThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Cecilia MennaThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.ORCID 0000-0002-9154-6919
Matteo TiracorrendoThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Domenico MassulloAnesthesiology and Intensive Care, Sant'Andrea Hospital, La Sapienza University, 00189 Rome, Italy.
Federico VenutaThoracic Surgery Policlinico Umberto I, La Sapienza University, 00186 Rome, Italy.
Erino Angelo RendinaThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Anna Maria CicconeThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Antonio D'AndrilliThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Mohsen IbrahimThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.
Giulio MauriziThoracic Surgery, Sant'Andrea, Hospital, La Sapienza University, 00189 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly post-operative airway management after laryngo-tracheal surgery is crucial. Acute respiratory failure due to glottis' edema may occur, requiring reintubation. This can prolong ventilatory assistance, jeopardizing anastomosis. To date, only judicious steroid administration and fluid management are available to avoid more invasive procedures. High-flow oxygen therapy (HFOT) is a noninvasive O

methodsBetween September 2020 and September 2022, 107 consecutive patients who underwent laryngo-tracheal surgery received HFOT (Group A). Data and long-term results were compared with those of 80 patients operated between September 2018 and August 2020 (Group B), when HFOT was not available. All patients were operated in a single center. No pre- or post-operative settings changed, except for HFOT introduction. We analyzed and compared the risk for "delayed" reintubation (unexpected reintubation within the first 24-48 h after extubating/laryngeal mask removal) in the two groups.

resultsNo patients reported HFOT-related adverse events. The control group (B) presented "delayed" reintubation in 37% (

conclusionsOur study is the first to investigate HFOT use in patients undergoing laryngo-tracheal surgery, potentially representing a consistent innovation in the peri-operative management of these patients. With the limitation of a retrospective series, we would suggest HFOT use for preventing post-operative reintubation rate, possibly reducing ICU admissions and hospital stays.

Indexed as

high-flow oxygen therapyperi-operative managementtracheal surgery

Identifiers

PMID38793037
PMCPMC11122413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.